Frisch Emily H, Yao Meng, Kim Hanna, Neumann Olivia, Chau Danielle B, Richards Elliott G, Beffa Lindsey
ObGyn and Women's Health Institute, Cleveland Clinic, Cleveland, OH 44124, USA.
Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH 44195, USA.
J Clin Med. 2024 Aug 11;13(16):4709. doi: 10.3390/jcm13164709.
Fertility preservation is an important part of oncologic care for newly diagnosed gynecologic cancers for reproductive-age women, as many treatment options negatively impact fertility. The goal of this study is to examine factors that influence access to fertility specialists for women with newly diagnosed gynecologic cancer. This institutional review board approved a retrospective cohort study investigating the impacting factors on the referral rate from gynecologic oncologists (GO) to reproductive endocrinologists and infertility (REI) specialists at a single academic institution between 2010-2022 for patients age 18-41 at diagnosis. Electronic medical records were used to identify demographics and referral patterns. Mixed logistic models were utilized to control cluster effects of the physicians. Of 816 patients reviewed, 410 met the criteria for inclusion. The referral rate for newly diagnosed gynecologic malignancies was 14.6%. Younger patients were more likely to have an REI referral ( < 0.001). The median time from first GO visit to treatment was 18.5 days, and there was no significant difference in those who had REI referrals ( = 0.44). Only 45.6% of patients had fertility desire documented. A total of 42.7% had fertility-sparing treatment offered by a GO. REI referral did not significantly change the time to treatment ( = 0.44). An REI referral was more likely to be placed if that patient had no living children, no past medical history, or if the referring GO was female (OR = 11.46, 6.69, and 3.8, respectively). Fertility preservation counseling is a critical part of comprehensive cancer care; yet, the referral to fertility services remains underutilized in patients with newly diagnosed gynecologic cancer. By demonstrating these biases in REI referral patterns, we can optimize provider education to enhance fertility care coordination.
对于育龄期女性新诊断的妇科癌症患者而言,生育力保存是肿瘤治疗的重要组成部分,因为许多治疗方案会对生育力产生负面影响。本研究的目的是探讨影响新诊断妇科癌症女性患者获得生育专家服务的因素。该机构审查委员会批准了一项回顾性队列研究,调查2010年至2022年期间在单一学术机构中,妇科肿瘤学家(GO)将患者转诊至生殖内分泌与不孕症(REI)专家的影响因素,这些患者诊断时年龄在18至41岁之间。利用电子病历确定人口统计学特征和转诊模式。采用混合逻辑模型来控制医生的聚类效应。在审查的816例患者中,410例符合纳入标准。新诊断妇科恶性肿瘤的转诊率为14.6%。年轻患者更有可能被转诊至REI(<0.001)。从首次就诊GO到开始治疗的中位时间为18.5天,转诊至REI的患者与未转诊患者之间无显著差异(=0.44)。只有45.6%的患者记录有生育意愿。共有42.7%的患者接受了GO提供的保留生育力治疗。转诊至REI并未显著改变开始治疗的时间(=0.44)。如果患者没有在世子女、没有既往病史,或者转诊的GO为女性,则更有可能被转诊至REI(OR分别为11.46、6.69和3.8)。生育力保存咨询是综合癌症治疗的关键部分;然而,新诊断妇科癌症患者对生育服务的转诊利用率仍然较低。通过揭示REI转诊模式中的这些偏差,我们可以优化医疗服务提供者的教育,以加强生育护理协调。